Rain Oncology
CA - Newark
BiotechnologyFocus: Small Molecules
Rain Oncology is a life sciences company focused on Small Molecules.
Oncology
Funding Stage
PUBLIC
Open Jobs
0
Pipeline & Clinical Trials
Placebo
Cardiac RepolarizationClinical Trials (1)
NCT05758818A Study of Milademetan Administration on Cardiac Repolarization in Healthy Subjects
Phase 1Milademetan
Advanced Solid TumorClinical Trials (1)
NCT06090318Milademetan in Combination With Atezolizumab in Patients With Advanced Solid Tumors With CDKN2A Loss
Phase 1/2Sotorasib and Tarloxotinib
Non-Small Cell Lung CancerClinical Trials (1)
NCT05313009Tarlox and Sotorasib in Patients With KRAS G12C Mutations
Phase 1/2Milademetan
Advanced or Metastatic Breast CancerClinical Trials (1)
NCT05932667Milademetan and Fulvestrant in GATA3-mutant, ER+HER- Advanced or Metastatic Breast Cancer
Phase 2RAIN-32
Solid TumorsClinical Trials (1)
NCT05012397Milademetan in Advanced/Metastatic Solid Tumors
Phase 2tarloxotinib bromide
NSCLC, Stage IVClinical Trials (1)
NCT03805841Study of Tarloxotinib in Pts With NSCLC (EGFR Exon 20 Insertion, HER2-activating Mutations) & Other Solid Tumors With NRG1/ERBB Gene Fusions
Phase 2TH-4000
Non-small Cell Lung CancerClinical Trials (1)
NCT02454842Study for Treatment With TH-4000 (Tarloxotinib) in Epidermal Growth Factor Receptor (EGFR) Mutant, T790M-negative Non-small Cell Lung Cancer (NSCLC) Patients
Phase 2Phase 2
Clinical Trials (1)
NCT02449681Study for Treatment of Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck or Skin
Phase 2RAIN-32
Dedifferentiated LiposarcomaClinical Trials (1)
NCT04979442Treatment of Milademetan Versus Trabectedin in Patient With Dedifferentiated Liposarcoma
Phase 3Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Founded: 2022
Portfolio: 9 clinical trials